Skip to main content
ASAM 2024 State of the Art Course Main banner
Final Program


Final Program
Back
Q & A

Comorbidities

Early Liver Transplantation for Severe Alcoholic Hepatitis

Thursday, October 17, 2024
10:50 AM – 11:10 AM ET
Location: Grand Ballroom I-V, Level 3

    Presenter(s)

  • Robert M. Weinrieb, MD

    Chief Psychiatric Consultant, Penn Transplant Institute and Program Director Consultation-Liaison Psychiatry Fellowship
    University of Pennsylvania, Perelman School of Medicine
    University of Pennsylvania, Perelman School of Medicine, Pennsylvania

    Slides
The most common cause of liver failure requiring liver transplantation in the United States is excessive alcohol consumption. Without liver transplantation, patients with Alcohol Associated Hepatitis (AAH) that fail medical management have survival rates of ~30%. U.S. Transplant teams encountered substantial increases in the prevalence of AAH in younger, sicker patients with short sobriety subsequent to the COVID-19 Pandemic. This session will describe two new outpatient programs developed to improve treatment adherence and reduce relapse in this high-risk population; 1. "Total Recovery", a 12-week program exclusively for liver transplant patients with Alcohol Use Disorders; 2. "The Integrated Liver Transplant Engagement and Recovery Network (ILEARN)", an NIH-funded, co-located program for Post-Liver Transplant Management of Alcohol Use Disorders

Learning Objectives:

Learners will be able to:
  • Describe rates of treatment acceptance, attendance and completion, relapse, health consequences and patient satisfaction in two specialized treatment programs developed exclusively for patients with Alcohol Associated Liver Disease (AAH) and short sobriety requiring early liver transplantation